Dyslipidemia in Japanese Patients with Rheumatoid Arthritis

Dyslipidemia in Japanese Patients with Rheumatoid Arthritis: A Retrospective Multicentre Observational Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN58708001

Enrollment

500

Registered

2010-06-29

Start date

2009-06-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis Musculoskeletal Diseases Other rheumatoid arthritis

Interventions

Non-interventional, observational study. The blood samples from a cohort of patients being treated with lipid-lowering drugs will be taken at baseline, 2, 4, 6, 8 months after administration. Informat

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age > 18 yrs 2. Fulfilled the 1987 revised criteria for RA of the American College of Rheumatology 3. Access to medical record information

Exclusion criteria

Exclusion criteria: History of medical conditions other than RA which may affect lipid profile

Design outcomes

Primary

Measure	Time frame
1. To investigate the lipid profile and estimate the prevalence of dyslipidemia 2. To determine the relationships between the lipid profiles and the RA disease activity, or the treatments such as Disease Modifying Antirheumatic Drugs (DMARDs), biologics, glucocorticoids.	—

Secondary

Measure	Time frame
To investigate the effect of administered statins in the treatment of dyslipidemia in Japanese patients with RA.	—

Countries

Japan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026